Predictors of survival in a series of clinically diagnosed progressive supranuclear palsy patients
Tóm tắt
Từ khóa
Tài liệu tham khảo
Steele, 1964, Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia, Arch Neurol, 10, 333, 10.1001/archneur.1964.00460160003001
Nath, 2001, The prevalence of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome) in the UK, Brain, 24, 1438, 10.1093/brain/124.7.1438
Williams, 2005, Characteristics of two clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-Parkinsonism, Brain, 128, 1247, 10.1093/brain/awh488
Williams, 2007, Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy, Mov Disord, 22, 2235, 10.1002/mds.21698
Donker Kaat, 2007, Frontal presentation in progressive supranuclear palsy, Neurology, 69, 723, 10.1212/01.wnl.0000267643.24870.26
Golbe, 1988, Prevalence and natural history of progressive supranuclear palsy, Neurology, 38, 1031, 10.1212/WNL.38.7.1031
Litvan, 1996, Natural history of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome) and clinical predictors of survival: a clinicopathological study, J Neurol Neurosurg Psychiatr, 61, 615, 10.1136/jnnp.60.6.615
Nath, 2003, Clinical features and natural history of progressive supranuclear palsy. A clinical cohort study, Neurology, 60, 910, 10.1212/01.WNL.0000052991.70149.68
Papapetropoulos, 2005, Natural history of progressive supranuclear palsy: a clinicopathological study from a population of brain donors, Eur Neurol, 54, 1, 10.1159/000086754
Golbe, 2007, A clinical rating scale for progressive supranuclear palsy, Brain, 130, 1552, 10.1093/brain/awm032
O'Sullivan, 2008, Clinical outcomes of progressive supranuclear palsy and multiple system atrophy, Brain, 131, 1362, 10.1093/brain/awn065
Lang, 2005, Treatment of progressive supranuclear palsy and corticobasal degeneration, Mov Disord, 20, S83, 10.1002/mds.20545
Stamelou, 2008, Short term effects of coenzyme Q10 in progressive supranuclear palsy: a randomize, placebo-controlled trial, Mov Disord, 23, 942, 10.1002/mds.22023
Bensimon, 2009, Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study, Brain, 132, 156, 10.1093/brain/awn291
Litvan, 1996, Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome): report of the NINDS-SPSP international workshop, Neurology, 47, 1, 10.1212/WNL.47.1.1
2000
Maher, 1986, The clinical features and natural history of the Steele–Richardson–Olszewski syndrome (progressive supranuclear palsy), Neurology, 36, 1005, 10.1212/WNL.36.7.1005
Santacruz, 1998, Progressive supranuclear palsy: a survey of the disease course, Neurology, 50, 1637, 10.1212/WNL.50.6.1637
Testa, 2001, Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy, Neurol Sci, 22, 247, 10.1007/s100720100021
Diroma, 2003, Natural history and clinical features of progressive supranuclear palsy: a clinical study, Neurol Sci, 24, 176, 10.1007/s10072-003-0117-z
Goetz, 2003, Progression of gait, speech and swallowing deficits in progressive supranuclear palsy, Neurology, 60, 917, 10.1212/01.WNL.0000052686.97625.27
Chiu, 2010, Survival in progressive supranuclear palsy and frontotemporal dementia, J Neurol Neurosurg Psychiatr, 81, 441, 10.1136/jnnp.2009.195719
Daniel, 1995, The clinical and pathological spectrum of Steele–Richardson–Olszewski syndrome (progressive supranuclear palsy): a reappraisal, Brain, 118, 759, 10.1093/brain/118.3.759
Litvan, 1996, Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome), Neurology, 46, 922, 10.1212/WNL.46.4.922
Hughes, 2002, The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service, Brain, 125, 861, 10.1093/brain/awf080